Therapeutically equivalent to EpiPen®
Teva settles litigation with Mylan over Nuvigil - Pharmaceutical Technology
Teva Pharmaceutical Gains Approval For Generic EpiPen, Mylan Shares Flat
Teva or Mylan: Who Has the More Promising Revenue Trajectory?
Mylan Teva EpiPen Generic Auto-Injector Market
Teva Offers to Buy Mylan for $40 Billion - WSJ
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival | Ctech
Teva shares rival Mylan's pain as both hit two-year lows | Fierce Pharma
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma
Drugmaker Teva makes $40B bid for rival Mylan
Mylan rejects Teva takeover bid as too low | Mint
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
How Mylan tried to keep Teva from selling a generic EpiPen
Teva makes $40 billion offer for Mylan
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva prices EpiPen generic at $300, same price as Mylan generic
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva Projects Generic Version of EpiPen to Consist of a Quarter of US Market | The Jewish Press - JewishPress.com | Jewish News Syndicate (JNS) | 16 Adar I 5779 – February 21, 2019 | JewishPress.com
Lawmakers accuse drugmakers Mylan, Teva of 'coordinated obstruction'
The Teva vs. Mylan drug war - The Jerusalem Post
